LXRX Share Price

Open 15.17 Change Price %
High 15.37 1 Day 0.08 0.53
Low 15.01 1 Week -0.26 -1.67
Close 15.29 1 Month 1.41 10.16
Volume 521451 1 Year 6.59 75.75
52 Week High 19.62
52 Week Low 8.81
LXRX Important Levels
Resistance 2 15.62
Resistance 1 15.49
Pivot 15.22
Support 1 15.09
Support 2 14.96
NASDAQ USA Most Active Stocks
CTRP 47.59 1.13%
ADBE 119.47 -0.13%
FSLR 33.57 -8.33%
FSLR 33.57 -8.33%
CERN 55.37 0.18%
BIDU 186.01 0.21%
AAPL 137.11 0.30%
AAPL 137.11 0.30%
FB 136.12 1.79%
MASI 87.05 2.03%
More..
NASDAQ USA Top Gainers Stocks
VALV 0.05 66.67%
LOCM 0.09 50.00%
BASI 1.33 31.68%
WRES 0.09 28.57%
INAP 2.31 27.62%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
SKBI 0.10 25.00%
AETI 2.40 23.08%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
LLEN 0.01 -50.00%
LIWA 0.01 -50.00%
QTWW 0.08 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
More..

Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX)

LXRX Technical Analysis 3
As on 22nd Feb 2017 LXRX Share Price closed @ 15.29 and we RECOMMEND Buy for LONG-TERM with Stoploss of 15.01 & Buy for SHORT-TERM with Stoploss of 14.83 we also expect STOCK to react on Following IMPORTANT LEVELS.
LXRX Target for February
1st Target up-side 15.39
2nd Target up-side 16.13
3rd Target up-side 16.87
1st Target down-side 13.27
2nd Target down-side 12.53
3rd Target down-side 11.79
LXRX Other Details
Segment EQ
Market Capital 962548544.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.lexpharma.com
LXRX Address
LXRX
8800 Technology Forest Place
The Woodlands, TX 77381
United States
Phone: 281-863-3000
Fax: 281-863-8088
Interactive Technical Analysis Chart Lexicon Pharmaceuticals, Inc. ( LXRX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Lexicon Pharmaceuticals, Inc.
LXRX Business Profile
Lexicon Pharmaceuticals, Inc. (Lexicon Pharmaceuticals) is a biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease. Lexicon Pharmaceuticals uses its gene knockout technologies and an integrated platform of medical technologies to study the physiological and behavioral functions of almost 5,000 genes in mice and assessed the utility of the proteins encoded by the corresponding human genes as drug targets. It has five drug programs in various stages of clinical development and has advanced small molecule compounds from a number of additional drug programs into various stages of preclinical development and research. Its drug program includes LX4211, LX1032, LX1033, LX2931 and LX7101.